Heparin sodium salt

Cat. No. 2812

Heparin sodium salt   [9041-08-1]

Price and Availability

For Heparin sodium salt pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Biological Activity

Minimum activity: > 150 I.U./mg. Glycosaminoglycan that behaves as an anticoagulant. Binds with high affinity to antithrombin III (AT-III).

Technical Data

Solubility:
Soluble to 50 mg/ml in water
Storage:
Desiccate at RT
CAS No:
9041-08-1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch
Select another batch:
Safety Data Sheet: View Safety Data Sheet

Lever and Page (2002) Novel drug development opportunities for heparin. Nat.Rev.Drug Discov. 1 140. PMID: 12120095.

If you know of a relevant reference for this product please let us know.

Citations are publications that use Tocris products. Selected citations for Heparin sodium salt include:

Bakri et al (2016) Embryo apoptosis identification: Oocyte grade or cleavage stage? Saudi J Biol Sci 23 S50. PMID: 26858565.

You et al (2015) Impact of Nanotopography, Heparin Hydrogel Microstructures, and Encapsulated Fibroblasts on Phenotype of Primary Hepatocytes. ACS Appl Mater Interfaces 7 12299. PMID: 25247391.

Do you know of a great paper that uses Heparin sodium salt from Tocris? If so please let us know.

View Related Products by Target

View Related Products by Product Action

Keywords: Heparin sodium salt, supplier, Anticoagulant, heparin, Adhesion, Molecules, antithrombin, III, Tocris Bioscience, Cell Adhesion Molecule products

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Product Guide

Our Cancer Research Guide highlights over 750 products for cancer research. Request copy or view PDF today.

divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Life Science Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance. Request copy today.

divider line

Bio-Techne Events

IVBM 2016

IVBM 2016

October 30 - November 3, 2016

Boston, MA, USA

Booth: 2